Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
6.36
0.00 (0.00%)
At close: Nov 6, 2026
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $1.23 billion as of November 9, 2026. It is the 8,934th most valuable company in the world and the 2,101st biggest in the United States. Its market cap has increased by 316.81% in one year.
Market Cap
1.23B
Enterprise Value
1.16B
Revenue
615.00K
Global Rank
Country Rank
#2,101 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has increased from 538.37M to 1.23B, an increase of 128.19%. That is a compound annual growth rate of 14.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 1.23B | 327.35% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CytoDyn | 337.70M |
| Northwest Biotherapeutics | 297.06M |
| Glorywin Entertainment Group | 234.77M |
| HST Global | 209.33M |
| BetterLife Pharma | 92.36M |
| Vaxart | 89.98M |
| ProText Mobility | 66.81M |
| Nuo Therapeutics | 51.82M |